From Our Partners
Saturday, June 25, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

NIH, CDC Small Business Innovation for Medical Countermeasures

by Global Biodefense Staff
November 12, 2012

An extended proposal deadline has been issued by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) for a Small Business Innovation Research (SBIR) contract solicitation.

The agencies seek small businesses that possess the research and development expertise to conduct innovative research that will contribute toward meeting their program objectives.

An abbreviated list of topics of interest includes: 

National Institute of Allergy and Infectious Diseases (NIAID): Integrated Multiplex Medical Diagnostics Platforms for Infectious Diseases; Aerosolized Delivery of Anti-Tubercular Drugs; Development of Long-Acting Formulations of HIV Anti-Retrovirals; Improved Formulations for Approved First and Second line anti-Tuberculosis (TB) Drugs 

National Center for Immunization and Respiratory Diseases (NCIRD): Development of an Inactivated Rotavirus Vaccine for Use in Global Immunization; Thermostable Dry Measles Vaccine Formulation for Sublingual Administration

National Center for Emerging Zoonotic and Infectious Diseases (NCEZID): Development of Nanoparticle Dengue Diagnostic Tests; Development of Tests in a Standardized Kit Format for Diagnosis of Arboviral Infections in Resource-Limited, Primary Health Care Setting; Reducing Antimicrobial Resistance through Improved use of Laboratory Testing Information in Healthcare Facilities

CDC Center for Global Health (CGH): Diagnostic Needs for Neglected Tropical Diseases (NTD) Programs; Rapid Screening Tests to Prevent Congenital Infections and Ensure Blood Safety; Development of Diagnostic Tests for Strongyloidiasis and Schistosomiasis 

National Center for Advancing Translational Sciences (NCATS): Assay Development for High-Throughput Screening of Chemicals of Toxicological Concern; Visualizing Knowledge about Human Health and the Pathways of Translation; Biomarker Study for Creatine Transporter Defect Disorders; Automated Instrument to Clean Microtiter Plates 

National Heart, Lung and Blood Institute (NHLBI): Improving Safety and Efficacy of Red Blood Cells for Transfusion; Fluorescent Nanodiamonds for In Vitro and In Vivo Biological Imaging

National Cancer Institute (NCI): RNAi Cancer Therapeutics using Nanotechnology; Development of Human Tissue Culture Systems that Mimic the Tumor Microenvironment; Development of CTC Isolation Technologies Enabling Downstream Single Cell Molecular Analysis; Wound Healing Preparations Incorporating Nitric Oxide-Releasing Materials; Technology to Generate Anti-Peptide Capture Reagents for Affinity-Enriched Proteomic Studies; Chemically Defined Glycan Libraries for Reference Standards and Glycomics Research; Novel Imaging Agents to Expand the Clinical Toolkit; Innovative Radiation Sources for Advanced Radiotherapy Equipment

Office of Public Health Preparedness and Response (OPHPR): Improved Methods for Collection, Preservation, and Transportation of Biological Specimens

Further details are available under Solicitation Number: PHS2013-1.  The proposal response deadline was recently extended to December 3, 2012.

From Our Partners
Tags: AntimicrobialsBiomarkersDengueMultiplexNanotechNeglected Tropical DiseasesNIHRequest for ProposalsThermostabilityVaccines

Related Posts

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine
Medical Countermeasures

Monkeypox Cases Prompt Additional Contracts for Bavarian Nordic Vaccine

May 30, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC